Physician belief themes | Enfuvirtide-prescriber category | Case scenarios | ||
---|---|---|---|---|
 | 'Higher' (≥ 5 patients currently prescribed)b (n = 175) | 'Non' (no patients currently prescribed)c (n = 120) | Physicians selecting enfuvirtide option | |
 |  |  | Case 1d (n = 323) | Case 2e (n = 214) |
Personal confidence in the efficacy of enfuvirtide and its use in practice | 3.35¶ (2.20, 5.08) | 0.32¶ (0.19, 0.53) | 2.44¶ (1.62, 3.66) | 2.10‡ (1.44, 3.07) |
Enfuvirtide is associated with treatment refusal and nonadherence | NS | 2.05‡ (1.29, 3.25) | 0.59†(0.40, 0.86) | 0.69* (0.47, 0.99) |
Enfuvirtide is difficult to justify in terms of time and resources | 0.63* (0.42, 0.94) | 1.69* (1.07, 2.64) | 0.57‡ (0.39, 0.83) | NS |
An enfuvirtide treatment offer is likely to jeopardize patients' trust | 0.56‡ (0.37, 0.83) | 1.86†(1.19, 2.92) | NS | NS |
Patients are likely to perceive that drawbacks of enfuvirtide outweigh its benefits | NS | NS | NS | NS |
Concerns about the risks of self-injectable therapies | NS | NS | 0.52¶ (0.37, 0.78) | NS |
Enfuvirtide is more suitable for nonadherent/chaotic patients | NS | NS | NS | 2.44¶ (1.67, 3.57) |